India's Pharmaceutical Exports

Country Profile

Pakistan

Pakistan is a significant market for Indian pharmaceutical exports — $177M in FY 2025–26, with 1.7× growth over the past decade. Vaccines accounts for 51% of shipments, with vaccines contributing $89.9M. The compound annual growth rate since FY2015 stands at 4.7%.

🇵🇰 $177M · 1.7× growth since FY2015 · 4.7% CAGR
Single-source profile. All data from DGCIS India export records (fiscal year, April–March).
$177M
Exports FY2025–26 DGCIS
1.7×
Growth FY2015→2026
4.7%
CAGR FY2015→2026
51%
Vaccines Share
5
Product Categories Supplied
Pakistan is a significant market for Indian pharmaceutical exports — $177M in FY 2025–26, with 1.7× growth over the past decade. Vaccines accounts for 51% of shipments, with vaccines contributing $89.9M. The compound annual growth rate since FY2015 stands at 4.7%.
Export Trend DGCIS FY
Category Mix — FY 2025–26 DGCIS
Vaccines $89.9M (50.8%) Medicine Ingredients $45.8M (25.9%) Medicines $41.0M (23.2%) Surgical & Hospital Supplies $207K (0.1%) Traditional & Herbal $19K (0.0%)
Top 10 Products — FY 2025–26 DGCIS
Indian Pharma Investment Source: RBI ODI Data

No recorded pharmaceutical sector investment transactions from Indian companies to Pakistan in the RBI overseas direct investment dataset (2011–2026).